Asia-Pacific Nuclear Medicine/Radiopharmaceutic Industry 2017 Market Research Report

Published: Nov, 2017 | Pages: 115 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

In this report, the Asia-Pacific Nuclear Medicine/Radiopharmaceutic market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (MT), revenue (Million USD), market share and growth rate of Nuclear Medicine/Radiopharmaceutic for these regions, from 2012 to 2022 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

Asia-Pacific Nuclear Medicine/Radiopharmaceutic market competition by top manufacturers/players, with Nuclear Medicine/Radiopharmaceutic sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    China Isotope Radiation
    Dongcheng
    Jaco
    Ciaeriar
    Advanced Molecular-imaging Solution
    Shanghai Atom Kexing
    Cardinal Health
    Mallinckrodt
    GE Healthcare
    Lantheus Medical Imaging
    Bayer Healthcare
    Bracco Imaging
    Eczacibasi-Monrol Nuclear Products
    Nordion
    Advanced Accelerator Applications
    Iba Molecular Imaging

On the basis of product, this report displays the sales volume (MT), revenue (Million USD), product price (USD/Kg), market share and growth rate of each type, primarily split into
    Diagnostic
    Therapeutic

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (MT), market share and growth rate of Nuclear Medicine/Radiopharmaceutic for each application, includin
    Oncology
    Thyroid
    Cardiology
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 Table of Contents

Asia-Pacific Nuclear Medicine/Radiopharmaceutic Market Report 2017
1 Nuclear Medicine/Radiopharmaceutic Overview
    1.1 Product Overview and Scope of Nuclear Medicine/Radiopharmaceutic
    1.2 Classification of Nuclear Medicine/Radiopharmaceutic by Product Category
        1.2.1 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Market Size (Sales) Comparison by Types (2012-2022)
        1.2.2 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Diagnostic
        1.2.4 Therapeutic
    1.3 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Market by Application/End Users
        1.3.1 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales (Volume) and Market Share Comparison by Applications (2012-2022)
        1.3.2 Oncology
        1.3.3 Thyroid
        1.3.4 Cardiology
        1.3.5 Others
    1.4 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Market by Region
        1.4.1 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 China Status and Prospect (2012-2022)
        1.4.3 Japan Status and Prospect (2012-2022)
        1.4.4 South Korea Status and Prospect (2012-2022)
        1.4.5 Taiwan Status and Prospect (2012-2022)
        1.4.6 India Status and Prospect (2012-2022)
        1.4.7 Southeast Asia Status and Prospect (2012-2022)
        1.4.8 Australia Status and Prospect (2012-2022)
    1.5 Asia-Pacific Market Size (Value and Volume) of Nuclear Medicine/Radiopharmaceutic (2012-2022)
        1.5.1 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2012-2022)
        1.5.2 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Asia-Pacific Nuclear Medicine/Radiopharmaceutic (Volume and Value) by Type
        2.2.1 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Type (2012-2017)
        2.2.2 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Type (2012-2017)
    2.3 Asia-Pacific Nuclear Medicine/Radiopharmaceutic (Volume) by Application
    2.4 Asia-Pacific Nuclear Medicine/Radiopharmaceutic (Volume and Value) by Region
        2.4.1 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Region (2012-2017)
        2.4.2 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Region (2012-2017)

3 China Nuclear Medicine/Radiopharmaceutic (Volume, Value and Sales Price)
    3.1 China Nuclear Medicine/Radiopharmaceutic Sales and Value (2012-2017)
        3.1.1 China Nuclear Medicine/Radiopharmaceutic Sales Volume and Growth Rate (2012-2017)
        3.1.2 China Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2012-2017)
        3.1.3 China Nuclear Medicine/Radiopharmaceutic Sales Price Trend (2012-2017)
    3.2 China Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Type
    3.3 China Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Application

4 Japan Nuclear Medicine/Radiopharmaceutic (Volume, Value and Sales Price)
    4.1 Japan Nuclear Medicine/Radiopharmaceutic Sales and Value (2012-2017)
        4.1.1 Japan Nuclear Medicine/Radiopharmaceutic Sales Volume and Growth Rate (2012-2017)
        4.1.2 Japan Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2012-2017)
        4.1.3 Japan Nuclear Medicine/Radiopharmaceutic Sales Price Trend (2012-2017)
    4.2 Japan Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Type
    4.3 Japan Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Application

5 South Korea Nuclear Medicine/Radiopharmaceutic (Volume, Value and Sales Price)
    5.1 South Korea Nuclear Medicine/Radiopharmaceutic Sales and Value (2012-2017)
        5.1.1 South Korea Nuclear Medicine/Radiopharmaceutic Sales Volume and Growth Rate (2012-2017)
        5.1.2 South Korea Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2012-2017)
        5.1.3 South Korea Nuclear Medicine/Radiopharmaceutic Sales Price Trend (2012-2017)
    5.2 South Korea Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Type
    5.3 South Korea Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Application

6 Taiwan Nuclear Medicine/Radiopharmaceutic (Volume, Value and Sales Price)
    6.1 Taiwan Nuclear Medicine/Radiopharmaceutic Sales and Value (2012-2017)
        6.1.1 Taiwan Nuclear Medicine/Radiopharmaceutic Sales Volume and Growth Rate (2012-2017)
        6.1.2 Taiwan Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2012-2017)
        6.1.3 Taiwan Nuclear Medicine/Radiopharmaceutic Sales Price Trend (2012-2017)
    6.2 Taiwan Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Type
    6.3 Taiwan Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Application

7 India Nuclear Medicine/Radiopharmaceutic (Volume, Value and Sales Price)
    7.1 India Nuclear Medicine/Radiopharmaceutic Sales and Value (2012-2017)
        7.1.1 India Nuclear Medicine/Radiopharmaceutic Sales Volume and Growth Rate (2012-2017)
        7.1.2 India Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2012-2017)
        7.1.3 India Nuclear Medicine/Radiopharmaceutic Sales Price Trend (2012-2017)
    7.2 India Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Type
    7.3 India Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Application

8 Southeast Asia Nuclear Medicine/Radiopharmaceutic (Volume, Value and Sales Price)
    8.1 Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales and Value (2012-2017)
        8.1.1 Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Volume and Growth Rate (2012-2017)
        8.1.2 Southeast Asia Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2012-2017)
        8.1.3 Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Price Trend (2012-2017)
    8.2 Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Type
    8.3 Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Application

9 Australia Nuclear Medicine/Radiopharmaceutic (Volume, Value and Sales Price)
    9.1 Australia Nuclear Medicine/Radiopharmaceutic Sales and Value (2012-2017)
        9.1.1 Australia Nuclear Medicine/Radiopharmaceutic Sales Volume and Growth Rate (2012-2017)
        9.1.2 Australia Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2012-2017)
        9.1.3 Australia Nuclear Medicine/Radiopharmaceutic Sales Price Trend (2012-2017)
    9.2 Australia Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Type
    9.3 Australia Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Application

10 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Players/Suppliers Profiles and Sales Data
    10.1 China Isotope Radiation
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 China Isotope Radiation Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2012-2017)
        10.1.4 Main Business/Business Overview
    10.2 Dongcheng
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 Dongcheng Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2012-2017)
        10.2.4 Main Business/Business Overview
    10.3 Jaco
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
            10.3.2.1 Product A
            10.3.2.2 Product B
        10.3.3 Jaco Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2012-2017)
        10.3.4 Main Business/Business Overview
    10.4 Ciaeriar
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
            10.4.2.1 Product A
            10.4.2.2 Product B
        10.4.3 Ciaeriar Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2012-2017)
        10.4.4 Main Business/Business Overview
    10.5 Advanced Molecular-imaging Solution
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
            10.5.2.1 Product A
            10.5.2.2 Product B
        10.5.3 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2012-2017)
        10.5.4 Main Business/Business Overview
    10.6 Shanghai Atom Kexing
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
            10.6.2.1 Product A
            10.6.2.2 Product B
        10.6.3 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2012-2017)
        10.6.4 Main Business/Business Overview
    10.7 Cardinal Health
        10.7.1 Company Basic Information, Manufacturing Base and Competitors
        10.7.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
            10.7.2.1 Product A
            10.7.2.2 Product B
        10.7.3 Cardinal Health Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2012-2017)
        10.7.4 Main Business/Business Overview
    10.8 Mallinckrodt
        10.8.1 Company Basic Information, Manufacturing Base and Competitors
        10.8.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
            10.8.2.1 Product A
            10.8.2.2 Product B
        10.8.3 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2012-2017)
        10.8.4 Main Business/Business Overview
    10.9 GE Healthcare
        10.9.1 Company Basic Information, Manufacturing Base and Competitors
        10.9.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
            10.9.2.1 Product A
            10.9.2.2 Product B
        10.9.3 GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2012-2017)
        10.9.4 Main Business/Business Overview
    10.10 Lantheus Medical Imaging
        10.10.1 Company Basic Information, Manufacturing Base and Competitors
        10.10.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
            10.10.2.1 Product A
            10.10.2.2 Product B
        10.10.3 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2012-2017)
        10.10.4 Main Business/Business Overview
    10.11 Bayer Healthcare
    10.12 Bracco Imaging
    10.13 Eczacibasi-Monrol Nuclear Products
    10.14 Nordion
    10.15 Advanced Accelerator Applications
    10.16 Iba Molecular Imaging

11 Nuclear Medicine/Radiopharmaceutic Manufacturing Cost Analysis
    11.1 Nuclear Medicine/Radiopharmaceutic Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceutic

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Nuclear Medicine/Radiopharmaceutic Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Nuclear Medicine/Radiopharmaceutic Major Manufacturers in 2016
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Market Effect Factors Analysis
    14.1 Technology Progress/Risk
        14.1.1 Substitutes Threat
        14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

15 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Market Forecast (2017-2022)
    15.1 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Volume, Revenue and Price Forecast (2017-2022)
        15.1.1 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Volume and Growth Rate Forecast (2017-2022)
        15.1.2 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate Forecast (2017-2022)
        15.1.3 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Price and Trend Forecast (2017-2022)
    15.2 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.1 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Volume and Growth Rate Forecast by Region (2017-2022)
        15.2.2 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.3 China Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.4 Japan Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.5 South Korea Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.6 Taiwan Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.7 India Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.8 Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.9 Australia Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Growth Rate Forecast (2017-2022)
    15.3 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Price Forecast by Type (2017-2022)
        15.3.1 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Forecast by Type (2017-2022)
        15.3.2 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Type (2017-2022)
        15.3.3 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Price Forecast by Type (2017-2022)
    15.4 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
    17.1 Methodology/Research Approach
        17.1.1 Research Programs/Design
        17.1.2 Market Size Estimation
        17.1.3 Market Breakdown and Data Triangulation
    17.2 Data Source
        17.2.1 Secondary Sources
        17.2.2 Primary Sources
    17.3 Disclaimer

List of Tables and Figures

    Figure Product Picture of Nuclear Medicine/Radiopharmaceutic
    Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Volume (MT) by Type (2012-2022)
    Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type (Product Category) in 2016
    Figure Diagnostic Product Picture
    Figure Therapeutic Product Picture
    Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales (MT) by Application (2012-2022)
    Figure Asia-Pacific Sales Market Share of Nuclear Medicine/Radiopharmaceutic by Application in 2016
    Figure Oncology Examples
    Table Key Downstream Customer in Oncology
    Figure Thyroid Examples
    Table Key Downstream Customer in Thyroid
    Figure Cardiology Examples
    Table Key Downstream Customer in Cardiology
    Figure Others Examples
    Table Key Downstream Customer in Others
    Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Market Size (Million USD) by Region (2012-2022)
    Figure China Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Japan Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2012-2022)
    Figure South Korea Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Taiwan Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2012-2022)
    Figure India Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Southeast Asia Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Australia Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Volume (MT) and Growth Rate (2012-2022)
    Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Market Major Players Product Sales Volume (MT)(2012-2017)
    Table Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales (MT) of Key Players/Suppliers (2012-2017)
    Table Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Share by Players/Suppliers (2012-2017)
    Figure 2016 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Share by Players/Suppliers
    Figure 2017 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Share by Players/Suppliers
    Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Market Major Players Product Revenue (Million USD) 2012-2017
    Table Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) by Players/Suppliers (2012-2017)
    Table Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue Share by Players/Suppliers (2012-2017)
    Figure 2016 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue Share by Players
    Figure 2017 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue Share by Players
    Table Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Type (2012-2017)
    Table Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Share by Type (2012-2017)
    Figure Sales Market Share of Nuclear Medicine/Radiopharmaceutic by Type (2012-2017)
    Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Growth Rate by Type (2012-2017)
    Table Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Market Share by Type (2012-2017)
    Table Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue Share by Type (2012-2017)
    Figure Revenue Market Share of Nuclear Medicine/Radiopharmaceutic by Type (2012-2017)
    Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate by Type (2012-2017)
    Table Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Volume (MT) and Market Share by Region (2012-2017)
    Table Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Share by Region (2012-2017)
    Figure Sales Market Share of Nuclear Medicine/Radiopharmaceutic by Region (2012-2017)
    Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Market Share by Region in 2016
    Table Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Market Share by Region (2012-2017)
    Table Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue Share (%) by Region (2012-2017)
    Figure Revenue Market Share of Nuclear Medicine/Radiopharmaceutic by Region (2012-2017)
    Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Region in 2016
    Table Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Volume (MT) and Market Share by Application (2012-2017)
    Table Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Share (%) by Application (2012-2017)
    Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2012-2017)
    Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2012-2017)
    Figure China Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate (2012-2017)
    Figure China Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2012-2017)
    Figure China Nuclear Medicine/Radiopharmaceutic Sales Price (USD/Kg) Trend (2012-2017)
    Table China Nuclear Medicine/Radiopharmaceutic Sales Volume (MT) by Type (2012-2017)
    Table China Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type (2012-2017)
    Figure China Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type in 2016
    Table China Nuclear Medicine/Radiopharmaceutic Sales Volume (MT) by Applications (2012-2017)
    Table China Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Application (2012-2017)
    Figure China Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Application in 2016
    Figure Japan Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate (2012-2017)
    Figure Japan Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Japan Nuclear Medicine/Radiopharmaceutic Sales Price (USD/Kg) Trend (2012-2017)
    Table Japan Nuclear Medicine/Radiopharmaceutic Sales Volume (MT) by Type (2012-2017)
    Table Japan Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type (2012-2017)
    Figure Japan Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type in 2016
    Table Japan Nuclear Medicine/Radiopharmaceutic Sales Volume (MT) by Applications (2012-2017)
    Table Japan Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Application (2012-2017)
    Figure Japan Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Application in 2016
    Figure South Korea Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate (2012-2017)
    Figure South Korea Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2012-2017)
    Figure South Korea Nuclear Medicine/Radiopharmaceutic Sales Price (USD/Kg) Trend (2012-2017)
    Table South Korea Nuclear Medicine/Radiopharmaceutic Sales Volume (MT) by Type (2012-2017)
    Table South Korea Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type (2012-2017)
    Figure South Korea Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type in 2016
    Table South Korea Nuclear Medicine/Radiopharmaceutic Sales Volume (MT) by Applications (2012-2017)
    Table South Korea Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Application (2012-2017)
    Figure South Korea Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Application in 2016
    Figure Taiwan Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate (2012-2017)
    Figure Taiwan Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Taiwan Nuclear Medicine/Radiopharmaceutic Sales Price (USD/Kg) Trend (2012-2017)
    Table Taiwan Nuclear Medicine/Radiopharmaceutic Sales Volume (MT) by Type (2012-2017)
    Table Taiwan Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type (2012-2017)
    Figure Taiwan Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type in 2016
    Table Taiwan Nuclear Medicine/Radiopharmaceutic Sales Volume (MT) by Applications (2012-2017)
    Table Taiwan Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Application (2012-2017)
    Figure Taiwan Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Application in 2016
    Figure India Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate (2012-2017)
    Figure India Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2012-2017)
    Figure India Nuclear Medicine/Radiopharmaceutic Sales Price (USD/Kg) Trend (2012-2017)
    Table India Nuclear Medicine/Radiopharmaceutic Sales Volume (MT) by Type (2012-2017)
    Table India Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type (2012-2017)
    Figure India Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type in 2016
    Table India Nuclear Medicine/Radiopharmaceutic Sales Volume (MT) by Application (2012-2017)
    Table India Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Application (2012-2017)
    Figure India Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Application in 2016
    Figure Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate (2012-2017)
    Figure Southeast Asia Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Price (USD/Kg) Trend (2012-2017)
    Table Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Volume (MT) by Type (2012-2017)
    Table Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type (2012-2017)
    Figure Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type in 2016
    Table Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Volume (MT) by Applications (2012-2017)
    Table Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Application (2012-2017)
    Figure Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Application in 2016
    Figure Australia Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate (2012-2017)
    Figure Australia Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Australia Nuclear Medicine/Radiopharmaceutic Sales Price (USD/Kg) Trend (2012-2017)
    Table Australia Nuclear Medicine/Radiopharmaceutic Sales Volume (MT) by Type (2012-2017)
    Table Australia Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type (2012-2017)
    Figure Australia Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type in 2016
    Table Australia Nuclear Medicine/Radiopharmaceutic Sales Volume (MT) by Applications (2012-2017)
    Table Australia Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Application (2012-2017)
    Figure Australia Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Application in 2016
    Table China Isotope Radiation Nuclear Medicine/Radiopharmaceutic Basic Information List
    Table China Isotope Radiation Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
    Figure China Isotope Radiation Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate (2012-2017)
    Figure China Isotope Radiation Nuclear Medicine/Radiopharmaceutic Sales Market Share in Asia-Pacific (2012-2017)
    Figure China Isotope Radiation Nuclear Medicine/Radiopharmaceutic Revenue Market Share in Asia-Pacific (2012-2017)
    Table Dongcheng Nuclear Medicine/Radiopharmaceutic Basic Information List
    Table Dongcheng Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
    Figure Dongcheng Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate (2012-2017)
    Figure Dongcheng Nuclear Medicine/Radiopharmaceutic Sales Market Share in Asia-Pacific (2012-2017)
    Figure Dongcheng Nuclear Medicine/Radiopharmaceutic Revenue Market Share in Asia-Pacific (2012-2017)
    Table Jaco Nuclear Medicine/Radiopharmaceutic Basic Information List
    Table Jaco Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
    Figure Jaco Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate (2012-2017)
    Figure Jaco Nuclear Medicine/Radiopharmaceutic Sales Market Share in Asia-Pacific (2012-2017)
    Figure Jaco Nuclear Medicine/Radiopharmaceutic Revenue Market Share in Asia-Pacific (2012-2017)
    Table Ciaeriar Nuclear Medicine/Radiopharmaceutic Basic Information List
    Table Ciaeriar Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
    Figure Ciaeriar Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate (2012-2017)
    Figure Ciaeriar Nuclear Medicine/Radiopharmaceutic Sales Market Share in Asia-Pacific (2012-2017)
    Figure Ciaeriar Nuclear Medicine/Radiopharmaceutic Revenue Market Share in Asia-Pacific (2012-2017)
    Table Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceutic Basic Information List
    Table Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
    Figure Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate (2012-2017)
    Figure Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceutic Sales Market Share in Asia-Pacific (2012-2017)
    Figure Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceutic Revenue Market Share in Asia-Pacific (2012-2017)
    Table Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceutic Basic Information List
    Table Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
    Figure Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate (2012-2017)
    Figure Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceutic Sales Market Share in Asia-Pacific (2012-2017)
    Figure Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceutic Revenue Market Share in Asia-Pacific (2012-2017)
    Table Cardinal Health Nuclear Medicine/Radiopharmaceutic Basic Information List
    Table Cardinal Health Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
    Figure Cardinal Health Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate (2012-2017)
    Figure Cardinal Health Nuclear Medicine/Radiopharmaceutic Sales Market Share in Asia-Pacific (2012-2017)
    Figure Cardinal Health Nuclear Medicine/Radiopharmaceutic Revenue Market Share in Asia-Pacific (2012-2017)
    Table Mallinckrodt Nuclear Medicine/Radiopharmaceutic Basic Information List
    Table Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
    Figure Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate (2012-2017)
    Figure Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales Market Share in Asia-Pacific (2012-2017)
    Figure Mallinckrodt Nuclear Medicine/Radiopharmaceutic Revenue Market Share in Asia-Pacific (2012-2017)
    Table GE Healthcare Nuclear Medicine/Radiopharmaceutic Basic Information List
    Table GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
    Figure GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate (2012-2017)
    Figure GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales Market Share in Asia-Pacific (2012-2017)
    Figure GE Healthcare Nuclear Medicine/Radiopharmaceutic Revenue Market Share in Asia-Pacific (2012-2017)
    Table Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Basic Information List
    Table Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
    Figure Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate (2012-2017)
    Figure Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales Market Share in Asia-Pacific (2012-2017)
    Figure Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Revenue Market Share in Asia-Pacific (2012-2017)
    Table Bayer Healthcare Nuclear Medicine/Radiopharmaceutic Basic Information List
    Table Bracco Imaging Nuclear Medicine/Radiopharmaceutic Basic Information List
    Table Eczacibasi-Monrol Nuclear Products Nuclear Medicine/Radiopharmaceutic Basic Information List
    Table Nordion Nuclear Medicine/Radiopharmaceutic Basic Information List
    Table Advanced Accelerator Applications Nuclear Medicine/Radiopharmaceutic Basic Information List
    Table Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Basic Information List
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price (USD/Kg) Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Nuclear Medicine/Radiopharmaceutic
    Figure Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceutic
    Figure Nuclear Medicine/Radiopharmaceutic Industrial Chain Analysis
    Table Raw Materials Sources of Nuclear Medicine/Radiopharmaceutic Major Manufacturers in 2016
    Table Major Buyers of Nuclear Medicine/Radiopharmaceutic
    Table Distributors/Traders List
    Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Volume (MT) and Growth Rate Forecast (2017-2022)
    Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Price (USD/Kg) and Trend Forecast (2017-2022)
    Table Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Volume (MT) Forecast by Region (2017-2022)
    Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share Forecast by Region (2017-2022)
    Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share Forecast by Region in 2022
    Table Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) Forecast by Region (2017-2022)
    Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue Market Share Forecast by Region (2017-2022)
    Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue Market Share Forecast by Region in 2022
    Figure China Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate Forecast (2017-2022)
    Figure China Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Japan Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate Forecast (2017-2022)
    Figure Japan Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure South Korea Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate Forecast (2017-2022)
    Figure South Korea Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Taiwan Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate Forecast (2017-2022)
    Figure Taiwan Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure India Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate Forecast (2017-2022)
    Figure India Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate Forecast (2017-2022)
    Figure Southeast Asia Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Australia Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate Forecast (2017-2022)
    Figure Australia Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Table Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales (MT) Forecast by Type (2017-2022)
    Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Market Share Forecast by Type (2017-2022)
    Table Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) Forecast by Type (2017-2022)
    Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue Market Share Forecast by Type (2017-2022)
    Table Asia-Pacific Nuclear Medicine/Radiopharmaceutic Price (USD/Kg) Forecast by Type (2017-2022)
    Table Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales (MT) Forecast by Application (2017-2022)
    Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Market Share Forecast by Application (2017-2022)
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

To request a free sample copy of this report, please complete the form below.

Interested in this report? Get your FREE sample now! Get a Free Sample

Did you know?

Our library has over 100000 reports on 1000s of topics

Over 100+ Fortune 500 companies rely on us

90,000+ people come to us for insights every month

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.